EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

3D Bioprinting for Next-Generation Personalized Medicine

Ethan Hau Yin Lam iD, Fengqing Yu, Sabrina Zhu, Zongjie Wang iD

International Journal of Molecular Sciences · 2023

DOI: 10.3390/ijms24076357 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Ethan Hau Yin Lam und 3 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Arts and Science, University of Toronto, Toronto, ON M5S 3G3, Canada. Hauptthemen laut MEDLINE: Tissue Engineering, Bioprinting. Die Arbeit wurde bisher 143-mal zitiert (Crossref) und nennt 93 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: STEM Fellowship, Indicium research competition hosted by STEM Fellowship.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

In the past decade, immense progress has been made in advancing personalized medicine to effectively address patient-specific disease complexities in order to develop individualized treatment strategies. In particular, the emergence of 3D bioprinting for in vitro models of tissue and organ engineering presents novel opportunities to improve personalized medicine. However, the existing bioprinted constructs are not yet able to fulfill the ultimate goal: an anatomically realistic organ with mature biological functions. Current bioprinting approaches have technical challenges in terms of precise cell deposition, effective differentiation, proper vascularization, and innervation. This review introduces the principles and realizations of bioprinting with a strong focus on the predominant techniques, including extrusion printing and digital light processing (DLP). We further discussed the applications of bioprinted constructs, including the engraftment of stem cells as personalized implants for regenerative medicine and in vitro high-throughput drug development models for drug discovery. While no one-size-fits-all approach to bioprinting has emerged, the rapid progress and promising results of preliminary studies have demonstrated that bioprinting could serve as an empowering technology to resolve critical challenges in personalized medicine.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Tissue EngineeringBioprintingHumansPrecision MedicinePrinting, Three-DimensionalRegenerative MedicineTissue Scaffolds

Stichwörter der Autor:innen

biomaterialbioprintingdrug discoverypersonalized medicineprecision medicineregenerative medicinestem cell

Autor:innen und Institutionen

  • Faculty of Arts and Science, University of Toronto, Toronto, ON M5S 3G3, Canada.
  • Department of Pharmacology & Toxicology, University of Toronto, Toronto, ON M5S 1A8, Canada.
  • Department of Nutritional Sciences, University of Toronto, Toronto, ON M5S 1A8, Canada.
  • Department of Computer Science, University of Toronto, Toronto, ON M5S 1A4, Canada.
  • Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON M5S 1A8, Canada.
  • Leslie Dan Faculty of Pharmacy, University of Toronto, Toronto, ON M5S 3M2, Canada.

ORCID-Profile: Ethan Hau Yin Lam, Zongjie Wang

Förderung

  • STEM Fellowship
  • Indicium research competition hosted by STEM Fellowship

Zitieren

APA

Lam, E. H. Y., Yu, F., Zhu, S., & Wang, Z. (2023). 3D Bioprinting for Next-Generation Personalized Medicine. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms24076357

Vancouver

Lam EHY, Yu F, Zhu S, Wang Z. 3D Bioprinting for Next-Generation Personalized Medicine. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms24076357

BibTeX
@article{Lam2023,
  author = {Lam, Ethan Hau Yin and Yu, Fengqing and Zhu, Sabrina and Wang, Zongjie},
  title = {3D Bioprinting for Next-Generation Personalized Medicine},
  journal = {International Journal of Molecular Sciences},
  year = {2023},
  doi = {10.3390/ijms24076357}
}
Kostenlos starten →